We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWS icon
1951
Zurn Elkay Water Solutions
ZWS
$8.38B
$3.67M ﹤0.01%
281,715
-55,120
-16% -$737K
TV icon
1952
Televisa
TV
$1.48B
$3.67M ﹤0.01%
+375,036
New +$3.39M
ETRN
1953
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$3.66M ﹤0.01%
251,835
+90,348
+56% +$1.39M
BLKB icon
1954
Blackbaud
BLKB
$1.94B
$3.66M ﹤0.01%
40,518
-4,480
-10% -$398K
BCPC
1955
Balchem Corp
BCPC
$5.38B
$3.66M ﹤0.01%
36,886
+13,249
+56% +$1.26M
AMED
1956
DELISTED
Amedisys
AMED
$3.65M ﹤0.01%
27,822
-588
-2% -$76.5K
CVET
1957
CALL
DELISTED
Covetrus, Inc. Common Stock
CVET
$3.64M ﹤0.01%
+305,800
New +$5.66M
WLL
1958
DELISTED
Whiting Petroleum Corporation
WLL
$3.63M ﹤0.01%
6,025
-2,542
-30% -$2.15M
PANW icon
1959
PUT
Palo Alto Networks
PANW
$270B
$3.63M ﹤0.01%
106,800
-118,200
-53% -$4.18M
WAFD icon
1960
WaFd
WAFD
$2.72B
$3.63M ﹤0.01%
98,104
+1,632
+2% +$58.3K
PTLA
1961
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.63M ﹤0.01%
135,264
+73,515
+119% +$2.06M
VRE
1962
DELISTED
Veris Residential
VRE
$3.62M ﹤0.01%
167,196
-6,527
-4% -$145K
SGI
1963
Somnigroup International
SGI
$13.7B
$3.62M ﹤0.01%
187,568
+12,796
+7% +$245K
OKE icon
1964
CALL
Oneok
OKE
$57.2B
$3.62M ﹤0.01%
+49,100
New +$3.47M
ILF icon
1965
iShares Latin America 40 ETF
ILF
$3.85B
$3.62M ﹤0.01%
114,505
+38,838
+51% +$1.25M
XLRE icon
1966
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
$3.61M ﹤0.01%
91,846
+32,147
+54% +$1.23M
SWN
1967
DELISTED
Southwestern Energy Company
SWN
$3.61M ﹤0.01%
1,868,924
+778,153
+71% +$1.67M
ENS icon
1968
EnerSys
ENS
$6.78B
$3.61M ﹤0.01%
54,692
+5,967
+12% +$375K
BRC icon
1969
Brady Corp
BRC
$4.44B
$3.6M ﹤0.01%
67,853
-3,032
-4% -$153K
CPE
1970
DELISTED
Callon Petroleum Company
CPE
$3.6M ﹤0.01%
82,908
+34,984
+73% +$1.71M
OLN icon
1971
Olin
OLN
$2.11B
$3.59M ﹤0.01%
191,736
+7,483
+4% +$141K
SLM icon
1972
SLM Corp
SLM
$4.89B
$3.59M ﹤0.01%
406,335
-46,076
-10% -$415K
HELE icon
1973
Helen of Troy
HELE
$644M
$3.58M ﹤0.01%
22,728
-7,663
-25% -$1.14M
AR icon
1974
Antero Resources
AR
$11.1B
$3.57M ﹤0.01%
1,183,449
+498,922
+73% +$2.03M
BGG
1975
DELISTED
Briggs & Stratton Corp.
BGG
$3.57M ﹤0.01%
589,416
+187,095
+47% +$1.38M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.